Company page
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. is a public company traded under the ticker AMLX in the American market. The company has a market capitalization of approximately $1.97 billion. Amylyx focuses on developing innovative therapies for neurological diseases.
- Ticker
- AMLX:NASDAQ
- Asset type
- Stock
- Market cap
- $4.36B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD